Global Insulin Pen and Pump Market was valued at USD 0.8 Billion in 2022 and is projected to reach USD 1.4 Billion by 2030, growing at a CAGR of 7.8% from 2024 to 2030.
The insulin pen and pump market is experiencing significant growth, driven by technological advancements and the increasing prevalence of diabetes worldwide. In 2023, the global insulin pump market was valued at approximately USD 6.05 billion and is projected to reach USD 10.57 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.22% during the forecast period. Similarly, the insulin delivery devices market, which includes insulin pens, was valued at USD 16.43 billion in 2023 and is expected to grow at a CAGR of 7.89% from 2024 to 2030.
Several factors contribute to this market expansion:
Rising Diabetes Prevalence: The International Diabetes Federation reported that approximately 537 million adults were living with diabetes globally in 2021, a number projected to rise to 642 million by 2040.
Technological Innovations: Companies are developing next-generation insulin pumps with advanced technology to enhance compliance and integration with IT devices. For instance, Medtronic's MiniMed 780G System, approved by the FDA in April 2023, is an advanced automated insulin delivery system for individuals aged 7 and older with type 1 diabetes.
Patient Preference for Convenience: Insulin pens and pumps offer more convenient and accurate insulin delivery methods compared to traditional syringes, leading to higher adoption rates among patients.
In my personal experience managing diabetes, transitioning from traditional insulin injections to using an insulin pump has been transformative. The ability to program basal and bolus doses has provided better blood sugar control and flexibility in daily activities. Additionally, the integration of continuous glucose monitoring with the pump has offered real-time insights, allowing for timely adjustments and improved overall health management.
However, the market faces challenges. For example, Novo Nordisk announced in November 2024 that it is gradually phasing out the production of human insulin pens globally, shifting focus towards more advanced insulin delivery methods. This move may impact patients in low and middle-income countries where human insulin is more commonly used due to its affordability.
Despite these challenges, the future of the insulin pen and pump market appears promising, with continuous innovations aimed at improving patient outcomes and quality of life.
Get an In-Depth Research Analysis of the Global Insulin Pen and Pump Market Size And Forecast [2025-2032]
Novo Nordisk
Eli Lilly
Sanofi
BD
Ypsomed Holding
Dongbao
Owen Mumford
Ganlee
Medtronic
Roche
Insulet Corp
Tandem Diabetes care
Valeritas
SOOIL
Microport
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Insulin Pen and Pump Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Insulin Pen and Pump Market
Hospital & Clinic
Retail Pharmacy
Online Sales
Based on Types the Market is categorized into Below types that held the largest Insulin Pen and Pump market share In 2023.
Insulin Pens
Insulin Pump
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Global, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Insulin Pen and Pump Market Research Analysis
1. Introduction of the Global Insulin Pen and Pump Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Insulin Pen and Pump Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Insulin Pen and Pump Market, By Type
6. Global Insulin Pen and Pump Market, By Application
7. Global Insulin Pen and Pump Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Insulin Pen and Pump Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/